Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial

Raquel Pei Chen Chan, Filomena Regina Barbosa Gomes Galas, Ludhmila Abrahão Hajjar, Carmen Narvaes Bello, Marilde Albuquerque Piccioni, José Otávio Costa Auler Jr, Raquel Pei Chen Chan, Filomena Regina Barbosa Gomes Galas, Ludhmila Abrahão Hajjar, Carmen Narvaes Bello, Marilde Albuquerque Piccioni, José Otávio Costa Auler Jr

Abstract

Background: The objective of this study was to investigate the relationship between different target levels of glucose and the clinical outcomes of patients undergoing cardiac surgery with cardiopulmonary bypass.

Methods: We designed a prospective study in a university hospital where 109 consecutive patients were enrolled during a six-month period. All patients were scheduled for open-heart surgery requiring cardiopulmonary bypass. Patients were randomly allocated into two groups. One group consisted of 55 patients and had a target glucose level of 80-130 mg/dl, while the other contained 54 patients and had a target glucose level of 160-200 mg/dl. These parameters were controlled during surgery and for 36 hours after surgery in the intensive care unit. Primary outcomes were clinical outcomes, including time of mechanical ventilation, length of stay in the intensive care unit, infection, hypoglycemia, renal or neurological dysfunction, blood transfusion and length of stay in the hospital. The secondary outcome was a combined end-point (mortality at 30 days, infection or length of stay in the intensive care unit of more than 3 days). A p-value of <0.05 was considered significant.

Results: The anthropometric and clinical characteristics of the patients from each group were similar, except for weight and body mass index. The mean glucose level during the protocol period was 126.69 mg/dl in the treated group and 168.21 mg/dl in the control group (p<0.0016). There were no differences between groups regarding clinical outcomes, including the duration of mechanical ventilation, length of stay in the intensive care unit, blood transfusion, postoperative infection, hypoglycemic event, neurological dysfunction or 30-day mortality (p>0.05).

Conclusions: In 109 patients undergoing cardiac surgery with cardiopulmonary bypass, both protocols of glycemic control in an intraoperative setting and in the intensive care unit were found to be safe, easily achieved and not to differentially affect clinical outcomes.

Trial registration: ClinicalTrials.gov NCT00370643.

Figures

Figure 1-
Figure 1-
Glucose levels (mg/dL) in control and intensively treated groups. Standard deviation is represented below

References

    1. Kernan WN, Viscoli CM, Inzucchi SE, Brass LM, Dawn M, Shulman GI. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke. Arch Intern Med. 2005;165:227–3.
    1. Dora B, Mihci E, Eser A, Ozclenir C, Caker M, Balaci MK. Prolonged hyperglycemia in the early subacute period after cerebral infarction: effects on short term prognosis. Acta Neurol Belg. 2004;104:64–7.
    1. Alvarez-Sabin J, Molina CA, Ribo M, Arenillas JF, Montaner J, Huertas R. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke. 2004;35:2493–8.
    1. Williams LS, Rotich J, Qi R, Fineberg A, Espay A, Bruno S. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology. 2002;59:67–7.
    1. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426–32.
    1. Suleiman M, Hammerman H, Boulos M, Kapeliorrich MR, Suleiman A, Agmon Y. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation. 2005;111:754–60.
    1. Kosuge M, Kimura K, Ishikawa T, Shimizi T, Hibi K, Toda N. Persistent hyperglycemia is associated with left ventricular dysfunction in patients with acute myocardial infarction. Circ J. 2005;69:23–8.
    1. Choi KM, Lee KW, Kim SG, Kim NH, Park CG, Suo HS. Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus. J Clin Endocrinol Metab. 2005;90:175–80.
    1. Timmer JR, van der Horst IC, Ottervanger JP, Henriques JPS, Hoortje JCA, Boer MJ. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J. 2004;148:399–404.
    1. Trence DL, Kelly JL, Hirsch IB. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change. J Clin Endocrinol Metab. 2003;88:2430–7.
    1. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma. 2004;56:1058–62.
    1. Vriesendorp TM, Morelis OJ, Devries JH, DeVries JH, Legemate DA, Hokstra JBL. Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery: a retrospective study. Eur J Vasc Endovasc Surg. 2004;28:520–5.
    1. Jeremitsky E, Omert LA, Dunham CM, Wilberger J, Rodriguez A. The impact of hyperglycemia on patients with severe brain injury. J Trauma. 2005;58:47–50.
    1. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care? J Clin Invest. 2004;114:1187–95.
    1. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471–8.
    1. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352–60.
    1. Furnary AP, Gao G, Grunkemeier GL, Grunkemeier GL, Wu YX, Zerr KJ. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007–21.
    1. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–67.
    1. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79:992–1000.
    1. Van den Berghe G, Wilmer A, Hermans G, Messerman W, Wouters PJ, Milants I. Intensive insulin therapy in medical intensive care patients. N Engl J Med. 2006;354:449–61.
    1. Vanhorebeek I, Langouche L, Van den Berghe G. Tight blood glucose control: What is the evidence? Critical Care Med. 2007;35(9 Suppl):S496–502.
    1. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F. Intensive insulin therapy in mixed medical/surgical ICU: benefit vs harm. Diabetes. 2006;55:3151–9.
    1. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O’Brien PC, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007;146:233–43.
    1. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N. Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis. N Engl J Med. 2008;358:125–39.
    1. Van den Berghe G. Does tight blood control glucose during cardiac surgery improve outcome? Ann Intern Med. 2007;146:307–8.
    1. Zerr K, Furnary A, Grunkemeier G, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetic after open heart operations. Ann Thorac Surg. 1997;63:356–61.
    1. Nashef S, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE®) Eur J Cardio Thoracic Surg. 1999;16:9–13.
    1. Tu J, Jaglal S, Naylor C. Interventional cardiology/cardiac surgery: multicenter validation of a risk index for mortality, intensive care unit stay, and overall hospital length of stay after cardiac surgery. Circulation. 1995;91:677–84.
    1. Bernstein A, Parsonnet V. Bedside estimation of risk as an aid for decision-making cardiac surgery. Ann Thorac Surg. 2000;69:823–8.
    1. Maharaj C, Laffey JG. New strategies to control the inflammatory response in cardiac surgery. Cur Op Anaesth. 2004;17:35–48.
    1. Farstad M, Heltne JK, Rynning SE, Onarheim H, Mongstad A, Eliassen F. Can the use of methylprednisolone, vitamin C, or α-trinisitol prevent cold-induced fluid extravasation during cardiopulmonary bypass in piglets. J Thorac Cardiovasc Surg. 2004;127:525–34.
    1. Boyle PJ, Schwartz NS, Shah SD, Clutter WE, Guyer PE. Plasma glucose concentration at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in non-diabetics. N Engl J Med. 1988;318:1487–92.
    1. Merimee TJ, Tyson JE. Stabilization of plasma glucose during fasting: Normal variation in two separate studies. N Engl J Med. 1974;291:1275–8.
    1. Vriesendorp TM, DeVries JH, van Santen S, Moeneralan HS, deJonge E, Ross YB. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med. 2006;34:2714–8.
    1. Muhlestein JB, Anderson JL, Horne BD, Lavasani F, Allen Maycock CA, Bair TL, Pearson RR, Carlquist JF, Intermountain Heart Collaborative Study Group Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J. 2003;146:351–8.
    1. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, Williams BA, Schrader LM, Rizza RA, McMahon MM. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005;80:862–6.
    1. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–8.
    1. Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma. 2003;55:33–8.
    1. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma. 2004;56:1058–62.
    1. Bochicchio GV, Sung J, Joshi M, Bochicchio K, Johnson SB, Meyer W, Scalea TM. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma. 2005;58:921–4.
    1. Sung J, Bochicchio GV, Joshi M, Bochicchio K, Tracy K, Scalea TM. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma. 2005;59:80–3.
    1. Rovlias A, Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery. 2000;46:335–42.
    1. Jeremitsky E, Omert LA, Dunham M, Wilberger J, Rodriguez A. The impact of hyperglycemia on patients with severe brain injury. J Trauma. 2005;58:47–50.
    1. Soo Hoo GW. Tight blood glucose control in the ICU: how best to measure glucose control? Chest. 2008;133:316–7.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa